NCT06581471View on ClinicalTrials.gov

The TRICURE EU Pivotal Study

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 29, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2030

Conditions
Tricuspid Valve RegurgitationHeart Valve DiseaseCardiovascular Diseases
Interventions
DEVICE

Transcatheter Tricuspid Valve Replacement

Replacement of the tricuspid valve through a transcatheter approach

Trial Locations (8)

1090

RECRUITING

UZ Brussel, Brussels

8800

RECRUITING

AZ Delta, Roeselare

9300

RECRUITING

Algemeen Stedelijk Ziekenhuis, Aalst

55131

NOT_YET_RECRUITING

University Medical Center of the Johannes Gutenberg University Mainz, Mainz

81377

RECRUITING

Ludwig Maximilian University Hospital, Munich

Unknown

RECRUITING

ZNA Middelheim, Antwerp

RECRUITING

Cliniques Universitaires Saint-Luc UCL, Brussels

NOT_YET_RECRUITING

Centre hospitalier universitaire CHU de Liège, Liège

Sponsors

Lead Sponsor

TRiCares
All Listed Sponsors
lead

TRiCares

INDUSTRY

NCT06581471 - The TRICURE EU Pivotal Study | Biotech Hunter | Biotech Hunter